Revolution Medicines, Inc.
RVMD
$99.00
$4.144.36%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.03B | 1.93B | 2.14B | 2.10B | 2.29B |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 49.36M | 45.98M | 39.27M | 31.91M | 38.33M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.08B | 1.98B | 2.18B | 2.13B | 2.33B |
|
|
|||||
| Total Current Assets | 2.08B | 1.98B | 2.18B | 2.13B | 2.33B |
| Net Property, Plant & Equipment | 165.28M | 167.38M | 147.05M | 142.93M | 141.82M |
| Long-term Investments | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M |
| Goodwill | 14.61M | 14.61M | 14.61M | 14.61M | 14.61M |
| Total Other Intangibles | 55.80M | 55.87M | 56.14M | 56.40M | 56.67M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 43.79M | 36.58M | 35.34M | 16.83M | 17.57M |
| Total Assets | 2.35B | 2.25B | 2.43B | 2.37B | 2.56B |
|
|
|||||
| Total Accounts Payable | 64.62M | 74.85M | 56.76M | 47.51M | 54.43M |
| Total Accrued Expenses | 201.48M | 146.21M | 114.22M | 97.46M | 96.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.47M | 16.33M | 13.09M | 12.98M | 12.87M |
| Total Finance Division Other Current Liabilities | 7.86M | 8.24M | 462.00K | 651.00K | 583.00K |
| Total Other Current Liabilities | 7.86M | 8.24M | 462.00K | 651.00K | 583.00K |
| Total Current Liabilities | 290.42M | 245.62M | 184.53M | 158.60M | 163.91M |
|
|
|||||
| Total Current Liabilities | 290.42M | 245.62M | 184.53M | 158.60M | 163.91M |
| Long-Term Debt | 268.45M | 256.51M | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 142.23M | 142.14M | 119.70M | 121.36M | 122.97M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 22.11M | 10.75M | 259.97M | 7.24M | 6.21M |
| Total Liabilities | 723.21M | 655.02M | 564.20M | 287.20M | 293.10M |
|
|
|||||
| Common Stock & APIC | 4.50B | 4.10B | 4.06B | 4.03B | 4.00B |
| Retained Earnings | -2.87B | -2.50B | -2.20B | -1.95B | -1.74B |
| Treasury Stock & Other | 3.24M | 3.12M | 1.30M | 1.71M | 1.32M |
| Total Common Equity | 1.63B | 1.60B | 1.87B | 2.08B | 2.27B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.63B | 1.60B | 1.87B | 2.08B | 2.27B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.63B | 1.60B | 1.87B | 2.08B | 2.27B |
|
|
|||||